Giorgio Cruciani
- Oncology top 2%
- Pulmonary and Respiratory Medicine top 2%
- Surgery top 5%
- Molecular Biology
- Physiology top 10%
- Co-authors
- Robert DeusonBruno DanieleGérard de PouvourvilleGedske DaugaardM. MarangoloPanagiotis MavrosSteven M. GrunbergEdward Rubenstein
- Topics
- Cancer Treatment and Pharmacology (17 papers)Lung Cancer Treatments and Mutations (11 papers)Prostate Cancer Treatment and Research (8 papers)
- Journals
- Journal of Clinical OncologyCancerInternational Journal of Radiation Oncology*Biology*Physics
- Partner nations
- ItalyUnited StatesFrance
In The Last Decade
Giorgio Cruciani
53 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 110
- Oncology 1.1k
- Pulmonary and Respiratory Medicine 850
- Surgery 655
- Molecular Biology 316
- Physiology 299
Countries citing papers authored by Giorgio Cruciani
This map shows the geographic impact of Giorgio Cruciani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giorgio Cruciani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giorgio Cruciani more than expected).
Fields of papers citing papers by Giorgio Cruciani
This network shows the impact of papers produced by Giorgio Cruciani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giorgio Cruciani. The network helps show where Giorgio Cruciani may publish in the future.
Co-authorship network of co-authors of Giorgio Cruciani
This figure shows the co-authorship network connecting the top 25 collaborators of Giorgio Cruciani. A scholar is included among the top collaborators of Giorgio Cruciani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giorgio Cruciani. Giorgio Cruciani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 28 | |
| 2 | 1 | |
| 3 | 15 | |
| 4 | 13 | |
| 5 | 17 | |
| 6 | 19 | |
| 7 | 25 | |
| 8 | 106 | |
| 9 | 18 | |
| 10 | 92 | |
| 11 | 358 | |
| 12 | 80 | |
| 13 | Combined use of gemcitabine and radiation in mice. | 8 |
| 14 | 19 | |
| 15 | 317 | |
| 16 | 37 | |
| 17 | STAGE D3 PROSTATIC CANCER TREATMENT WITH ORAL ESTRAMUSTINE PHOSPHATE AND ETOPOSIDE | 1 |
| 18 | 9 | |
| 19 | 12 | |
| 20 | 2 |
About Giorgio Cruciani
Giorgio Cruciani is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 55 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (17 papers), Lung Cancer Treatments and Mutations (11 papers) and Prostate Cancer Treatment and Research (8 papers). The work is most often cited by research in Oncology (1.1k citations), Pulmonary and Respiratory Medicine (850 citations) and Otorhinolaryngology (70 citations). Giorgio Cruciani has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Robert Deuson, Bruno Daniele, Gérard de Pouvourville, Gedske Daugaard, M. Marangolo, Panagiotis Mavros, Steven M. Grunberg, Edward Rubenstein, Mogens Hansen and Olga Geling. Their work appears in journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.